Quick Answer
TELA Bio, Inc. reported Stockholders Equity of $6.31 million for fiscal year 2025.
TELA Bio, Inc. Stockholders Equity — Annual History
| Fiscal Year | Stockholders Equity | YoY Change |
|---|---|---|
| 2025 | $6.31M | -77.8% |
| 2024 | $28.46M | +50.7% |
| 2023 | $18.88M | +32.0% |
| 2022 | $14.30M | -28.8% |
| 2021 | $20.10M | -59.0% |
| 2020 | $49.03M | +58.3% |
| 2019 | $30.96M | +122.5% |
| 2018 | -$137.86M | -27.4% |
| 2017 | -$108.17M | -33.3% |
| 2016 | -$81.17M | — |
Quarterly Stockholders Equity
| Quarter Ending | Stockholders Equity | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $1.56M | +124.8% | -83.0% |
| June 30, 2025 | $9.18M | +220.0% | -49.3% |
| March 31, 2025 | $18.12M | +26.0% | -36.3% |
| December 31, 2024 | $28.46M | +50.7% | +553.7% |
| September 30, 2024 | -$6.27M | -120.5% | -318.5% |
| June 30, 2024 | $2.87M | -92.8% | -80.0% |
| March 31, 2024 | $14.38M | +357.9% | -23.8% |
| December 31, 2023 | $18.88M | +32.0% | -38.2% |
- TELA Bio, Inc. showed a decrease of -77.8% in Stockholders Equity compared to the prior fiscal year.
- Over the 2016–2025 period, TELA Bio, Inc.’s stockholders equity has grown by 107.8% (from -$81.17 million to $6.31 million).
- The most recent figure is from TELA Bio, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 25, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: